JP Morgan Chase’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,700
Closed -$1.3M 7265
2023
Q1
$1.3M Sell
7,700
-8,400
-52% -$1.5M ﹤0.01% 3853
2022
Q4
$2.73M Buy
+16,100
New +$2.92M ﹤0.01% 3323
2021
Q1
Sell
-40,500
Closed -$7.76M 6300
2020
Q4
$7.76M Buy
+40,500
New +$7.37M ﹤0.01% 2415

Other funds holding RGEN

JP Morgan Chase's RGEN Position: Q1 2026 in Review

JP Morgan Chase reduced its Repligen (RGEN) stake by 48% in Q1 2026, selling an estimated $16.9M and leaving 128,221 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2374.

JP Morgan Chase first reported a position in RGEN in Q2 2014 and has held it in 44 quarters since. The position peaked at $98.2M in Q1 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • JP Morgan Chase held 128,221 shares of Repligen worth $14.3M as of Q1 2026.
  • JP Morgan Chase sold 120,716 Repligen shares in Q1 2026, an estimated $16.9M.
  • Repligen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2374 holding.
  • JP Morgan Chase first reported a position in Repligen in Q2 2014 and has held it in 44 quarters since.
  • JP Morgan Chase's Repligen position peaked at $98.2M in Q1 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.